Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2012
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029913A1 Oral preparation
03/08/2012WO2012029870A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient
03/08/2012WO2012029863A1 Sulfated polysaccharide capable of binding to growth factor and use thereof
03/08/2012WO2012029722A1 Screening method
03/08/2012WO2012029655A1 Agent for controlling hemodialysis-induced cramps
03/08/2012WO2012029367A1 Intestine immunomodulator
03/08/2012WO2012029326A1 3-pyrazolyl-2-pyridone derivative
03/08/2012WO2012028543A1 Composition comprising a combination of dha and epa for administration prior to commencement of chemotherapy
03/08/2012WO2012012300A3 Treatment of the adverse side-effects associated with administration of an anti-hyaluronan agent
03/08/2012WO2011146804A3 Gm3 ganglioside replacement therapy
03/08/2012WO2011009042A8 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120059064 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
03/08/2012US20120059049 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/08/2012US20120059025 Dry powder compound formulations and uses thereof
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058207 Anti-diabetic nutraceutical composition from palm leaf extract
03/08/2012US20120058156 Activated leukocyte composition and uses for wound healing
03/08/2012US20120058139 Novel multimodular assembly useful for intracellular delivery
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058113 Cancer treatment method
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058087 Diagnosis of endometritis
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012CA2809112A1 Cyclic amide derivative
03/07/2012EP2426139A1 CXCR4 antagonist and use thereof
03/07/2012EP2426126A1 Method for producing olmesartan medoxomil
03/07/2012EP2426121A1 Quaternary ammonium salt compound
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
03/07/2012EP2425857A1 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
03/07/2012EP2425833A1 Intravenous application of fish oils / DHA + EPA before or at the beginning of chemotherapy
03/07/2012EP2425831A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
03/07/2012EP2424522A1 Composition for removing atheromatous plaque
03/07/2012EP1982986B1 Pyrrolopyridazinone compound as pde4 inhibitor
03/07/2012EP1961767B1 Diagnosis and treatment of cancers and other conditions
03/07/2012EP1754702B1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012EP1348029B1 Materials and methods relating to protein aggregation in neurodegenerative disease
03/07/2012EP1289540B1 Oncomodulin for treating neurological disorders
03/07/2012EP1017353B1 Therapeutic process for inhibiting nf-kappa b
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN1549721B Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/07/2012CN102369283A Rnai molecule for thymidylate synthase and use thereof
03/07/2012CN102366558A Reagent for relieving heat toxin
03/07/2012CN102366543A Chinese herbal medicine for treating blood deficiency, blood heat and blood dryness
03/07/2012CN102366532A Chinese herbal medicine for treating scrofula and hernia caused by qi stagnation
03/07/2012CN101979082B Medicament for treating cyclomastopathy and preparation method and application thereof
03/07/2012CN101426491B GIP secretion inhibitor
03/07/2012CN101317915B Decoction medicament for treating deficiency of both qi and yin type kakidrosis
03/06/2012US8129552 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium
03/06/2012US8129541 5-phenylthiazole derivatives and use as PI3 kinase inhibitors
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129535 Alkyl ether derivatives or salts thereof
03/06/2012US8129405 Quinuclidine derivatives and medicinal compositions containing the same
03/06/2012US8129381 Caspase inhibitors and uses thereof
03/06/2012US8129378 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
03/06/2012US8129360 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129112 Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications
03/06/2012US8128924 Methods for using a three-dimensional stromal tissue to promote angiogenesis
03/06/2012CA2487734C Treatment with cytokines for alzheimer's disease
03/06/2012CA2486055C Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/06/2012CA2485532C Process for the preparation of 2-methyl piperazine derivatives
03/06/2012CA2483707C Microparticles bearing cells and active substances
03/06/2012CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
03/06/2012CA2452881C Novel bicyclic and tricyclic cannabinoids
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/06/2012CA2442694C Osteoprotegerin in milk
03/06/2012CA2434831C Polypeptide drug substances
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/06/2012CA2348998C Lipoic acid derivatives and their use in treatment of disease
03/01/2012WO2012026645A1 Method for treating and preventing sacbrood virus infection
03/01/2012WO2012026614A1 Composition suppressing matrix-metalloproteinase activity
03/01/2012WO2012026565A1 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
03/01/2012WO2012026526A1 Hemokinin-1 receptor and hemokinin-1-derived peptide
03/01/2012WO2012026511A1 Pharmaceutical composition
03/01/2012WO2012026495A1 Novel hydantoin derivative and medicinal agent comprising same as active ingredient
03/01/2012WO2012026491A1 Pluripotent stem cell cardiomyocyte differentiation-promoting agent
03/01/2012WO2012026346A1 Cytoprotective agent
03/01/2012WO2011137540A8 Gfi1b modulation and uses thereof
03/01/2012US20120053558 Tissue repair with multipotent cells
03/01/2012US20120053237 Oligomer-Amino Acid Conjugates
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053132 Compositions and methods for inhibiting cytochrome p450
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120052292 Novel medical device coatings
03/01/2012US20120052070 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/01/2012US20120052017 Method for producing contrast agent for optical imaging
03/01/2012US20120052011 Composition and a method for producing contrast agent using the composition
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 1564